Innophos, Inc.

University of Florida Research Foundation Inc

Kylie Mitchell

Jatinder Rana

George Christou

Described herein are compositions and methods relating to molecular cerium-oxide nanoclusters. In an aspect, described herein are methods of synthesizing molecular cerium-oxide nanocluster compositions and compositions thereof. In an aspect, described herein are methods of scavenging reactive oxygen species utilizing molecular cerium-oxide nanoclusters as described herein. Also described herein are pharmaceutical compositions and methods of use. Pharmaceutical compositions as described herein can comprise a therapeutically effective amount of a compound (such as a composition comprising one or more molecular cerium-oxide nanoclusters), or a pharmaceutically acceptable salt of the compound, and a pharmaceutically acceptable carrier. Methods of treating oxidative stress are also described herein, comprising administering pharmaceutical compositions as described herein to a subject in need thereof. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

Compositions and methods relating to molecular cerium-oxide nanoclusters

A botanical extract that exhibits anti-inflammatory activity, wherein the botanical extract is at least an extract from the leaf of

Anti-inflammatory botanical extract

Plant-based inhibitors of MMP-9 that also function as PPAR-γ agonists, and the use of such plant-based inhibitors/agonists in modulating metabolic disorders is disclosed. The plant-based inhibitor/agonist is at least an extract obtained from the leaf of the genus

Botanical modulator of metabolic disorders

A botanical extract that exhibits antioxidant activity, wherein the botanical extract is at least an extract from the genus

Botanical antioxidants

A botanical extract for use in skin care, wherein the botanical extract is at least an extract from the testa of the seed ofL.

Botanical extract for skin care

A botanical extract that exhibits anti-inflammatory activity, wherein the botanical extract is at least an extract from the genus

Plant-based inhibitors of MMP-9 that also function as PPAR-&#x3b3; agonists, and the use of such plant-based inhibitors/agonists in modulating metabolic disorders is disclosed. The plant-based inhibitor/agonist is at least an extract obtained from the genus

Plant-based inhibitors of MMP-9 that also function as PPAR-&#x3b3; agonists, and the use of such plant-based inhibitors/agonists in modulating metabolic disorders is disclosed. The plant-based inhibitor/agonist is at least an extract obtained from the leaf of the genus

A botanical extract that exhibits antioxidant activity, wherein the botanical extract is at least an extract from the leaf of a plant from the genus

Growing community of inventors

Pennington, NJ, United States of America

Kylie Mitchell